Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2012
09/20/2012US20120238728 Multivalent antibodies and uses therefor
09/20/2012US20120238727 Decorin compositions and use thereof
09/20/2012US20120238620 TRYPTOPHANYL-tRNA SYNTHETASE-DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238575 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
09/20/2012US20120238568 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
09/20/2012US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
09/20/2012US20120238523 Glycosaminoglycan mixtures
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238501 Modulation Of Osteoclast Differentiation
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120238497 Glp-1 fusion peptides, their production and use
09/20/2012US20120238496 Fusion protein regulating plasma glucose and lipid, its preparation method and use
09/20/2012US20120238491 Immunologically active lipopeptides and methods for use thereof
09/20/2012US20120238488 Compounds and methods for treating neoplasia
09/20/2012US20120238039 Novel immobilizing fusion protein for effective and oriented immobilization of antibody on surfaces
09/20/2012US20120238023 Novel Method for Producing Differentiated Cells
09/20/2012US20120238022 INDUCIBLE SYSTEMS AND METHODS FOR CONTROLLING siRNA EXPRESSION
09/20/2012US20120238021 Methods of synthesizing three-dimensional heteroatom-doped carbon nanotube macro materials and compositions thereof
09/20/2012US20120238020 Megakaryocyte and Platelet Production from Stem Cells
09/20/2012US20120238019 Stem cell culture media for maintaining stemness or inducing differentiation of stem cells
09/20/2012US20120238018 Caged Ceramide-1-Phosphate Derivatives
09/20/2012US20120238017 Novel sirna structure for minimizing off-target effects and relaxing saturation of rnai machinery and the use thereof
09/20/2012US20120238016 Specific nNOS Inhibitors for the Therapy And Prevention Of Human Melanoma
09/20/2012US20120238015 Methods and materials for increasing potency of cells
09/20/2012US20120238014 Pluripotent Cells from the Mammalian Late Epiblast Layer
09/20/2012US20120238013 Fusion partner for production of monoclonal rabbit antibodies
09/20/2012US20120238012 Cytotoxic t lymphocyte
09/20/2012US20120238001 Production of viral vaccines in suspension on avian embryonic derived stem cell lines
09/20/2012US20120238000 Immortalized avian cell lines
09/20/2012US20120237999 Herpes simplex viruses and methods of viral replication
09/20/2012US20120237981 Amylases, nucleic acids encoding them and methods for making and using them
09/20/2012US20120237979 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
09/20/2012US20120237976 Mammalian expression vectors and uses thereof
09/20/2012US20120237975 Engineered nucleic acids and methods of use thereof
09/20/2012US20120237974 Method for the expression of a recombinant protein in a mammalian cell
09/20/2012US20120237972 Mammalian-type glycosylation in plants
09/20/2012US20120237969 Method of Preparing Cells Susceptible to Transmissible Spongiform Encephalopathy and the Creation of TSE Persistently Infected Cells
09/20/2012US20120237946 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237926 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
09/20/2012US20120237607 Immortalized cell compositions and compositions derived therefrom
09/20/2012US20120237558 Method of treating an osteochondral defect
09/20/2012US20120237535 Therapeutic Compositions For The Treatment of HPV-Induced Diseases
09/20/2012US20120237529 Diagnostic antibody assay
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237526 Bace1 inhibitory antibodies
09/20/2012US20120237523 Neutralizing antibodies to hiv-1 and their use
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237520 Boris isoforms and methods of detecting and treating disease
09/20/2012US20120237519 Pestvirus species
09/20/2012US20120237518 Anti-trop-2 antibody
09/20/2012US20120237509 Anti-Mesothelin Antibodies
09/20/2012US20120237507 Monovalent Antigen Binding Proteins
09/20/2012US20120237506 Antigen Binding Proteins
09/20/2012US20120237496 Protease variants
09/20/2012US20120237487 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237486 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237485 Trabecular Meshwork Stem Cells
09/20/2012US20120237484 Generation of Functional Basal Forebrain Cholinergic Neurons From Stem Cells
09/20/2012US20120237481 Incorporation of the B18R gene to enhance antitumor effect of virotherapy
09/20/2012US20120237473 Compositions And Methods For Cell Based Retinal Therapies
09/20/2012US20120237449 Methods for treating neural cell swelling
09/20/2012US20120237443 Functionalizing implantable devices with a poly (diol citrate) polymer
09/20/2012US20120237441 Enhanced b cell cytotoxicity of cdim binding antibody
09/20/2012CA2830503A1 Method for making pluripotent stem cells
09/20/2012CA2830420A1 Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
09/20/2012CA2830250A1 Reactor systems
09/20/2012CA2830140A1 Probe for analyzing biological tissue and method for utilizing same
09/20/2012CA2829774A1 Method of viral production in cells
09/19/2012EP2500433A2 Improved yield and stress tolerance in transgenic plants
09/19/2012EP2500425A1 Particle-containing cell aggregate
09/19/2012EP2500420A1 Pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
09/19/2012EP2500418A1 Novel method for producing differentiated cells
09/19/2012EP2500417A1 Method of production of transgenic avian using embryonic stem cells
09/19/2012EP2500416A1 Cell culture improvements
09/19/2012EP2500415A1 Cell culture improvements
09/19/2012EP2500414A1 Cell culture improvements
09/19/2012EP2500413A1 Cell culture improvements
09/19/2012EP2500412A1 Method for producing fish cells with increased high quality unsaturated fatty acids and use of these fish cells to produce fish-specific products
09/19/2012EP2500410A1 Bioreactor with mechanical and electrical stimulation means
09/19/2012EP2500042A1 Cell sheet for myocardial regeneration, manufacturing method, and method of usage therefor
09/19/2012EP2499265A1 Device and method for culturing cells
09/19/2012EP2499261A2 Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
09/19/2012EP2499242A1 Methods to enhance delivery and engraftment of stem cells including the identification of specific prostagandin e2 receptors
09/19/2012EP2499241A2 Methods of generating neural stem cells
09/19/2012EP2499240A1 Subpopulations of spore-like cells and uses thereof
09/19/2012EP2499239A1 METHOD FOR GENERATION AND REGULATION OF iPS CELLS AND COMPOSITIONS THEREOF
09/19/2012EP2499238A1 Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
09/19/2012EP2499237A1 Reprogrammation of eukaryotic cells with engineered microvesicles
09/19/2012EP2499236A2 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
09/19/2012EP2498798A1 Compositions and methods for wound treatment
09/19/2012EP2498797A2 Treatment of heart disease
09/19/2012EP2498795A2 Granulysin in immunotherapy
09/19/2012CN1889979B IP-10 antibodies and their uses
09/19/2012CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
09/19/2012CN102686737A Method for producing fatty acid-containing lipid using thioesterase variant
09/19/2012CN102686725A Expansion medium for CD34-negative stem cells
09/19/2012CN102686724A Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
09/19/2012CN102686723A Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 1827